• 104 Citations
  • 5 h-Index
20112020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 104 Citations
  • 5 h-Index
  • 19 Article
2020

Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell culture

Kato, N., Ueda, Y., Sejima, H., Gu, W., Satoh, S., Dansako, H., Ikeda, M. & Shimotohno, K., Feb 2020, In : Archives of Virology. 165, 2, p. 331-343 13 p.

Research output: Contribution to journalArticle

2019

A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection

Ueda, Y., Gu, W., Dansako, H., Nishitsuji, H., Satoh, S., Shimotohno, K. & Kato, N., Jul 12 2019, In : Biochemical and Biophysical Research Communications. 515, 1, p. 156-162 7 p.

Research output: Contribution to journalArticle

Ribavirin-induced down-regulation of CCAAT/ enhancer-binding protein α leads to suppression of lipogenesis

Satoh, S., Onomura, D., Ueda, Y., Dansako, H., Honda, M., Kaneko, S. & Kato, N., Jan 15 2019, In : Biochemical Journal. 476, 1, p. 137-149 13 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2018
2 Citations (Scopus)

Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251

Ueda, Y., Gu, W., Dansako, H., Kim, H. S., Yoshizaki, S., Okumura, N., Ishikawa, T., Nishitsuji, H., Kato, F., Hishiki, T., Satoh, S., Ishii, K., Masuda, M., Shimotohno, K., Ikeda, M. & Kato, N., Sep 2018, In : Biochemistry and Biophysics Reports. 15, p. 1-6 6 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell-mediated innate immune response in human hepatocytes

Dansako, H., Imai, H., Ueda, Y., Satoh, S., Wakita, T. & Kato, N., Mar 2018, In : FEBS Open Bio. 8, 3, p. 361-371 11 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2017
5 Citations (Scopus)
2016

Synthesis and in vitro activity of pyrrolo[3,4-d]pyrimidine-2,5-diones as potential non-nucleoside HCV inhibitors

Mostafa, A. S., El Bialy, S. A., Bayoumi, W. A., Ueda, Y., Ikeda, M., Kato, N. & Abdelal, A. M., Aug 1 2016, In : Current Enzyme Inhibition. 12, 2, p. 170-176 7 p.

Research output: Contribution to journalArticle

The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly

Dansako, H., Ueda, Y., Okumura, N., Satoh, S., Sugiyama, M., Mizokami, M., Ikeda, M. & Kato, N., Jan 1 2016, In : FEBS Journal. 283, 1, p. 144-156 13 p.

Research output: Contribution to journalArticle

36 Citations (Scopus)
2015

Establishment of Hepatitis C Virus RNA-Replicating cell lines possessing ribavirin-resistant phenotype

Satoh, S., Mori, K., Ueda, Y., Sejima, H., Dansako, H., Ikeda, M. & Kato, N., Feb 20 2015, In : PLoS One. 10, 2, e0118313.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2014

Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris

Ueda, Y., Mori, K., Satoh, S., Dansako, H., Ikeda, M. & Kato, N., May 2 2014, In : Biochemical and Biophysical Research Communications. 447, 2, p. 341-345 5 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)

Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systems

Kato, N., Sejima, H., Ueda, Y., Mori, K., Satoh, S., Dansako, H. & Ikeda, M., Mar 13 2014, In : PloS one. 9, 3, e91156.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs

Matsuno, K., Ueda, Y., Fukuda, M., Onoda, K., Waki, M., Ikeda, M., Kato, N. & Miyachi, H., Sep 1 2014, In : Bioorganic and Medicinal Chemistry Letters. 24, 17, p. 4276-4280 5 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Synthesis of 3′,4′-difluoro-3′-deoxyribonucleosides and its evaluation of the biological activities: Discovery of a novel type of anti-HCV agent 3′,4′-difluorocordycepin

Shimada, H., Haraguchi, K., Hotta, K., Miyaike, T., Kitagawa, Y., Tanaka, H., Kaneda, R., Abe, H., Shuto, S., Mori, K., Ueda, Y., Kato, N., Snoeck, R., Andrei, G. & Balzarini, J., Nov 1 2014, In : Bioorganic and Medicinal Chemistry. 22, 21, p. 6174-6182 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2013

New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

Ueda, Y., Takeda, M., Mori, K., Dansako, H., Wakita, T., Kim, H. S., Sato, A., Wataya, Y., Ikeda, M. & Kato, N., Aug 30 2013, In : PloS one. 8, 8, e72519.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication

Ban, S., Ueda, Y., Ohashi, M., Matsuno, K., Ikeda, M., Kato, N. & Miyachi, H., Sep 1 2013, In : Bioorganic and Medicinal Chemistry Letters. 23, 17, p. 4774-4778 5 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2012

Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis C

Mori, K., Ueda, Y., Ariumi, Y., Dansako, H., Ikeda, M. & Kato, N., Jun 2012, In : Virus Genes. 44, 3, p. 374-381 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2011
12 Citations (Scopus)